T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.
about
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanomaDurable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapyApplications of next-generation sequencing to blood and marrow transplantationAn automated procedure to identify biomedical articles that contain cancer-associated gene variantsPersistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy.Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion.Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors.Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression.Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapyTherapeutic aspects of chaperones/heat-shock proteins in neuro-oncology.Immune correlates of melanoma survival in adoptive cell therapy.Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma.Cancer immunotherapy targeting neoantigens.Profound impairment of adaptive immune responses by alkylating chemotherapyA Tumor-Specific Neo-Antigen Caused by a Frameshift Mutation in BAP1 Is a Potential Personalized Biomarker in Malignant Peritoneal MesotheliomaCD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors.Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases.PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.HLA-binding properties of tumor neoepitopes in humans.Personalized cancer immunotherapy using Systems Medicine approaches.The neoepitope landscape in pediatric cancers.Tools to define the melanoma-associated immunopeptidome.Immune targets and neoantigens for cancer immunotherapy and precision medicine.'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorGetting personal with neoantigen-based therapeutic cancer vaccines.Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.Human Tumor Antigens and Cancer Immunotherapy.Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens.An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.T-cell therapy against cancer mutations.MicroRNAs Reprogram Tumor Immune Response.Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer
P2860
Q24548019-0DBBC14A-960B-4B31-A66D-5914CA12D504Q24596055-0CCF9F2E-6C93-4DC3-B166-2E001D99874DQ26852890-73949912-4B11-45CF-B9E7-2A1F65D08037Q28253911-6EBC93E6-38CF-4343-B318-D0310FF10901Q33210267-20C06A5C-6223-4FD5-B106-A2A7128EF22DQ33261122-3C5D7078-F5F9-441D-B31A-7FD1BF48A5F6Q34216825-3709DB7B-ABF7-48B7-B93C-6B30455C7D26Q34669675-9D5CEFAD-D5DC-4AB9-9CF8-60794125B5A6Q36327111-A256099F-78D5-4DD9-A60C-B66295A39789Q36328394-F82C106C-F9D6-4120-AFF2-81EDD155311EQ36499222-9C30347A-59E8-49CC-BC22-44B508A27E5FQ36694896-3F4776A3-EE2B-498D-9C41-07B8253C2471Q36757025-2A4338C7-9B64-4410-AA60-5DE38FCEB836Q36889067-AFB988EE-9FC3-4C0E-899A-562E7D211E70Q36922577-82AD187B-4569-43DF-8020-F67F4094763BQ36939300-B5E9E73B-EFF9-462F-B294-BE61C94F5B52Q37074414-106BB020-B2FE-447C-A726-726F384B5DB9Q37477282-C642DD35-37E5-4409-A83E-FC77BEFBDE93Q37726682-5E36DD55-B419-4877-8778-607FE3104382Q37851050-74093BD1-6CB9-428B-AEB7-4ACF0BB8CAA7Q38217357-A8ABCD55-D230-433B-A445-863DAB41AD16Q38547040-4634CE30-190A-4A35-B52C-ACDB4D6BFD97Q38601828-27FCDEA2-ABD4-46F0-97D3-EF20865B7436Q38650013-362A6289-56E9-4CDD-8639-B168036B1D6EQ39057617-2B9E4BAD-DC92-4F7E-B0EE-21599922E4D7Q39136403-AD41F2D7-23AF-4209-9E5B-9286214C2B83Q39647119-E66CAE35-5DEA-4B9D-B507-5BEB05871BD3Q39945813-B595CA95-8814-401D-B028-EAC7B42DB1FEQ40259357-58DE228C-ADA4-4F1C-8C5D-778A7137886FQ41533232-E4106BE3-5CE4-459E-8C3D-B87EC20D2964Q41958978-189AE678-16AA-4D7D-A685-93A167543849Q42632718-75E762D5-5357-4B56-91BA-1B9D8A95179CQ42848657-715D6269-F46C-49B5-B9D7-79020564A9C9Q45873784-A9654259-F8E9-43E2-AEA9-B1090F400A4EQ49432766-F63D2DC4-B319-4724-AAB7-BE112CB0EB79Q57152489-A8D0CC09-2195-4D20-855E-E34F736EC3F6
P2860
T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
T cells associated with tumor ...... ated HLA class I gene product.
@ast
T cells associated with tumor ...... ated HLA class I gene product.
@en
type
label
T cells associated with tumor ...... ated HLA class I gene product.
@ast
T cells associated with tumor ...... ated HLA class I gene product.
@en
prefLabel
T cells associated with tumor ...... ated HLA class I gene product.
@ast
T cells associated with tumor ...... ated HLA class I gene product.
@en
P2093
P2860
P1476
T cells associated with tumor ...... ated HLA class I gene product.
@en
P2093
Jianping Huang
Mark E Dudley
Mona El-Gamil
Paul F Robbins
Steven A Rosenberg
P2860
P304
P356
10.4049/JIMMUNOL.172.10.6057
P407
P577
2004-05-01T00:00:00Z